Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

progression

progression is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 15
Pipeline programs 18
News articles 0
Drug details — progression
Class
—
Route
—
Patents
15
Programs
18
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

progression is an FDA-listed pharmaceutical active ingredient.

Key facts

INN progression

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. BB2121-MM-003 Phase 3 · Celgene · Multiple myeloma (MM) with at least 2 prior therapies includ
  2. C5091017 Phase 3 · First Biotech (Australia) · Covid-19 at high risk of progression to severe illness.
  3. CA2660001 Phase 3 · Bristol-Myers Squibb Australia · Unresectable Stage III non-small cell lung cancer without pr
  4. Grafalon 20 mg/ml concentrato per soluzione per infusione Phase 3 · George Institute for · To analyze whether the anti-rejection treatment of borderlin
  5. NN9535-4352 Phase 3 · NovoThirteen · While it is well-established that long-term good glycaemic c
  6. Qarziba 4.5 mg/mL concentrate for solution for infusion Phase 3 · COLLEGIUM PHARMACEUTICAL · Recurrent or progression of neuroblastoma or neuroblastoma o
  7. UC-GTG-2301 Phase 3 · Ningbo Cancer Hospital · Novo metastatic hormone-sensitive prostate cancer (mHSPC) pa
  8. 2023/3668 Phase 2 · George Institute for · Patients with HER2-positive (HER2-pos) (cohort 1) or HER2-lo

Related patents

Browse patents

  1. WO 2025233516

    MÉTHODE D'AUGMENTATION DU TEMPS JUSQU'À LA DEUXIÈME PROGRESSION ET DU TEMPS JUSQU'À LA PREMIÈRE CHIMIOTHÉRAPIE SUIVANTE

    Expires Wed Nov 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11052089

    Methods for inhibiting alpha-v beta-3 expression on cancer stem cells and inhibiting progression to a cancer stem cell phenotype

    Expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9315534

    Radiologic agents for monitoring alzheimer's disease progression and Evaluating a Response to Therapy and processes for the preparation of such agents

    Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7053263

    Mouse models of human prostate cancer progression

    Expires Mon May 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 6956145

    Mice models of human prostate cancer progression

    Expires Mon Oct 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  6. US 6949690

    Methods of assessing the effect of a gene of interest on human prostate cancer progression

    Expires Mon Sep 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  7. US 6815574

    Methods of simulating human prostate cancer progression

    Expires Mon Nov 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  8. US 6790615

    Methods and compositions for regulating cell cycle progression

    Expires Mon Sep 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  9. US 6689561

    Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment

    Expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  10. US 6600030

    Delayed progression to aids by a missense allele of the CCR2 gene

    Expires Mon Jul 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  11. US 6365797

    Mice models of human prostate cancer progression

    Expires Mon Mar 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  12. US 6245752

    Compositions and methods for tolerization in immune complex-mediated disease progression

    Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  13. US 6224866

    Immunotherapy of B cell involvement in progression of solid, nonlymphoid tumors

    Expires Mon Apr 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  14. US 6183961

    Methods and compositions for regulating cell cycle progression

    Expires Mon Feb 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  15. US 6107540

    Mice models of human prostate cancer progression

    Expires Mon Aug 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is progression?

progression is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.